These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22190348)

  • 1. Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexes.
    Nazaré M; Matter H; Will DW; Wagner M; Urmann M; Czech J; Schreuder H; Bauer A; Ritter K; Wehner V
    Angew Chem Int Ed Engl; 2012 Jan; 51(4):905-11. PubMed ID: 22190348
    [No Abstract]   [Full Text] [Related]  

  • 2. Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
    Shi Y; O'Connor SP; Sitkoff D; Zhang J; Shi M; Bisaha SN; Wang Y; Li C; Ruan Z; Lawrence RM; Klei HE; Kish K; Liu EC; Seiler SM; Schweizer L; Steinbacher TE; Schumacher WA; Robl JA; Macor JE; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7516-21. PubMed ID: 22041058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally active zwitterionic factor Xa inhibitors with long duration of action.
    Mochizuki A; Nagata T; Kanno H; Takano D; Kishida M; Suzuki M; Ohta T
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7337-43. PubMed ID: 22044620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-fluoroindazoles as potent and selective inhibitors of factor Xa.
    Lee YK; Parks DJ; Lu T; Thieu TV; Markotan T; Pan W; McComsey DF; Milkiewicz KL; Crysler CS; Ninan N; Abad MC; Giardino EC; Maryanoff BE; Damiano BP; Player MR
    J Med Chem; 2008 Jan; 51(2):282-97. PubMed ID: 18159923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand.
    Nazaré M; Essrich M; Will DW; Matter H; Ritter K; Urmann M; Bauer A; Schreuder H; Czech J; Lorenz M; Laux V; Wehner V
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4197-201. PubMed ID: 15261269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding affinities of factor Xa inhibitors estimated by thermodynamic integration and MM/GBSA.
    Genheden S; Nilsson I; Ryde U
    J Chem Inf Model; 2011 Apr; 51(4):947-58. PubMed ID: 21417269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.
    Kochanny MJ; Adler M; Ewing J; Griedel BD; Ho E; Karanjawala R; Lee W; Lentz D; Liang AM; Morrissey MM; Phillips GB; Post J; Sacchi KL; Sakata ST; Subramanyam B; Vergona R; Walters J; White KA; Whitlow M; Ye B; Zhao Z; Shaw KJ
    Bioorg Med Chem; 2007 Mar; 15(5):2127-46. PubMed ID: 17227710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding binding selectivity toward trypsin and factor Xa: the role of aromatic interactions.
    Di Fenza A; Heine A; Koert U; Klebe G
    ChemMedChem; 2007 Mar; 2(3):297-308. PubMed ID: 17191291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents.
    Nazaré M; Essrich M; Will DW; Matter H; Ritter K; Urmann M; Bauer A; Schreuder H; Dudda A; Czech J; Lorenz M; Laux V; Wehner V
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4191-5. PubMed ID: 15261268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand.
    Choi-Sledeski YM; Kearney R; Poli G; Pauls H; Gardner C; Gong Y; Becker M; Davis R; Spada A; Liang G; Chu V; Brown K; Collussi D; Leadley R; Rebello S; Moxey P; Morgan S; Bentley R; Kasiewski C; Maignan S; Guilloteau JP; Mikol V
    J Med Chem; 2003 Feb; 46(5):681-4. PubMed ID: 12593648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of glycine and related amino acid-based factor Xa inhibitors.
    Kohrt JT; Filipski KJ; Cody WL; Bigge CF; La F; Welch K; Dahring T; Bryant JW; Leonard D; Bolton G; Narasimhan L; Zhang E; Peterson JT; Haarer S; Sahasrabudhe V; Janiczek N; Desiraju S; Hena M; Fiakpui C; Saraswat N; Sharma R; Sun S; Maiti SN; Leadley R; Edmunds JJ
    Bioorg Med Chem; 2006 Jul; 14(13):4379-92. PubMed ID: 16529937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.
    Watson NS; Adams C; Belton D; Brown D; Burns-Kurtis CL; Chaudry L; Chan C; Convery MA; Davies DE; Exall AM; Harling JD; Irvine S; Irving WR; Kleanthous S; McLay IM; Pateman AJ; Patikis AN; Roethke TJ; Senger S; Stelman GJ; Toomey JR; West RI; Whittaker C; Zhou P; Young RJ
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1588-92. PubMed ID: 21349711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa.
    Mederski WW; Dorsch D; Anzali S; Gleitz J; Cezanne B; Tsaklakidis C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3763-9. PubMed ID: 15203158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors.
    Yoshikawa K; Yoshino T; Yokomizo Y; Uoto K; Naito H; Kawakami K; Mochizuki A; Nagata T; Suzuki M; Kanno H; Takemura M; Ohta T
    Bioorg Med Chem Lett; 2011 Apr; 21(7):2133-40. PubMed ID: 21345673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of benzamidine-type inhibitors of factor Xa.
    Gabriel B; Stubbs MT; Bergner A; Hauptmann J; Bode W; Stürzebecher J; Moroder L
    J Med Chem; 1998 Oct; 41(22):4240-50. PubMed ID: 9784099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new Factor Xa inhibitor from Amblyomma cajennense with a unique domain composition.
    Batista IF; Ramos OH; Ventura JS; Junqueira-de-Azevedo IL; Ho PL; Chudzinski-Tavassi AM
    Arch Biochem Biophys; 2010 Jan; 493(2):151-6. PubMed ID: 19853573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational tools for the analysis and visualization of multiple protein-ligand complexes.
    O'Brien SE; Brown DG; Mills JE; Phillips C; Morris G
    J Mol Graph Model; 2005 Dec; 24(3):186-94. PubMed ID: 16169759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa.
    Ueno H; Katoh S; Yokota K; Hoshi J; Hayashi M; Uchida I; Aisaka K; Hase Y; Cho H
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4281-6. PubMed ID: 15261287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.